DE69028514D1 - Leukämiehemmender faktor aus vieharten und seine verwendung zur verbesserung der implantation und der entwicklung von embryonalen zellen - Google Patents

Leukämiehemmender faktor aus vieharten und seine verwendung zur verbesserung der implantation und der entwicklung von embryonalen zellen

Info

Publication number
DE69028514D1
DE69028514D1 DE69028514T DE69028514T DE69028514D1 DE 69028514 D1 DE69028514 D1 DE 69028514D1 DE 69028514 T DE69028514 T DE 69028514T DE 69028514 T DE69028514 T DE 69028514T DE 69028514 D1 DE69028514 D1 DE 69028514D1
Authority
DE
Germany
Prior art keywords
leakoma
livestock
implanting
improving
inhibiting factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69028514T
Other languages
English (en)
Other versions
DE69028514T2 (de
Inventor
Nicholas Gough
Tracey Willson
Robert Seamark
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CSL Innovation Pty Ltd
Original Assignee
Amrad Corp Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amrad Corp Ltd filed Critical Amrad Corp Ltd
Application granted granted Critical
Publication of DE69028514D1 publication Critical patent/DE69028514D1/de
Publication of DE69028514T2 publication Critical patent/DE69028514T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5415—Leukaemia inhibitory factor [LIF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0604—Whole embryos; Culture medium therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/235—Leukemia inhibitory factor [LIF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Wood Science & Technology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE69028514T 1989-01-10 1990-01-09 Leukämiehemmender faktor aus vieharten und seine verwendung zur verbesserung der implantation und der entwicklung von embryonalen zellen Expired - Fee Related DE69028514T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AUPJ222089 1989-01-10
AUPJ270689 1989-02-13
AUPJ486089 1989-06-23
PCT/AU1990/000001 WO1990008188A1 (en) 1989-01-10 1990-01-09 Leukaemia inhibitory factor from livestock species and use thereof to enhance implantation and development of embryonic cells

Publications (2)

Publication Number Publication Date
DE69028514D1 true DE69028514D1 (de) 1996-10-17
DE69028514T2 DE69028514T2 (de) 1997-02-20

Family

ID=27157475

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69028514T Expired - Fee Related DE69028514T2 (de) 1989-01-10 1990-01-09 Leukämiehemmender faktor aus vieharten und seine verwendung zur verbesserung der implantation und der entwicklung von embryonalen zellen

Country Status (8)

Country Link
US (3) US5418159A (de)
EP (1) EP0453453B1 (de)
JP (1) JP2974760B2 (de)
AT (1) ATE142695T1 (de)
CA (1) CA2045126A1 (de)
DE (1) DE69028514T2 (de)
NZ (1) NZ232072A (de)
WO (1) WO1990008188A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2045126A1 (en) * 1989-01-10 1990-07-11 Nicholas M. Gough Leukaemia inhibitory factor from livestock species and use thereof to enhance implantation and development of embryonic cells
WO1992001040A1 (en) * 1990-07-09 1992-01-23 Amrad Corporation Limited Enhanced implantation, development and maintenance of embryos using leukaemia inhibitory factor
US5589582A (en) * 1992-10-27 1996-12-31 Biotransplant, Inc. Polynucleotides en coding porcine cytokines
WO1995020661A1 (en) * 1994-01-27 1995-08-03 Bresatec Ltd. Materials and methods for management of hyperacute rejection in human xenotransplantation
US5849991A (en) * 1994-01-27 1998-12-15 Bresatch Limited Mice homozygous for an inactivated α 1,3-galactosyl transferase gene
JP2002511732A (ja) 1996-10-11 2002-04-16 ザ・テキサス・エイ・アンド・エム・ユニヴァーシティ・システム トランスジェニック動物を発生させるための組成物および方法
US6177545B1 (en) * 1997-09-02 2001-01-23 Insight Strategy & Marketing Ltd. Heparanase specific molecular probes and their use in research and medical applications
US6699672B1 (en) 1997-09-02 2004-03-02 Insight Biopharmaceuticals Ltd. Heparanase specific molecular probes and their use research and medical applications
US20020088019A1 (en) * 1997-09-02 2002-07-04 Oron Yacoby-Zeevi Methods of and pharmaceutical compositions for improving implantation of embryos
US20010006630A1 (en) * 1997-09-02 2001-07-05 Oron Yacoby-Zeevi Introducing a biological material into a patient
US20040213789A1 (en) * 1997-09-02 2004-10-28 Oron Yacoby-Zeevi Heparanase activity neutralizing anti-heparanase monoclonal antibody and other anti-heparanase antibodies
AUPP053197A0 (en) * 1997-11-26 1997-12-18 Amrad Operations Pty. Limited Compositions
AU2680999A (en) * 1998-02-19 1999-09-06 University Of Southern California Method of promoting embryonic stem cell proliferation
JP2002519387A (ja) * 1998-07-06 2002-07-02 ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ， アズ レプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ 体外受精のための組成物および方法
US20030217375A1 (en) * 1998-08-31 2003-11-20 Eyal Zcharia Transgenic animals expressing heparanase and uses thereof
WO2000052178A1 (en) * 1999-03-01 2000-09-08 Insight Strategy & Marketing Ltd. Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells
US6635802B1 (en) 2000-01-10 2003-10-21 The Texas A&M University System Nuclear transfer using cells cultured in serum starvation media containing apoptosis inhibitors
JP3723839B2 (ja) * 2001-06-07 2005-12-07 国立大学法人広島大学 ニワトリの白血病阻止因子（ｌｉｆ）、及びそれをコードする遺伝子
US6671189B2 (en) * 2001-11-09 2003-12-30 Minebea Co., Ltd. Power converter having primary and secondary side switches
DE60239420D1 (de) * 2001-12-21 2011-04-21 Thrombogenics Nv Zusammensetzungen für die in vitro herleitung und kultur embryonaler stammzellinien mit keimbahnübertragungsfähigkeit und für die kultur adulter stammzellen
AU2002218893A1 (en) * 2001-12-21 2003-07-09 Thromb-X Nv Compositions for the in vitro derivation and culture of embryonic stem (es) cell lines with germline transmission capability
GB0220145D0 (en) * 2002-08-30 2002-10-09 Thromb X Nv Novel compositions for the in vitro derivation and culture of embryonic stem (ES) cell lines with germline transmission capability
WO2004108065A2 (en) * 2003-06-09 2004-12-16 Insight Biopharmaceuticals Ltd. Heparanase activity neutralizing anti- heparanase monoclonal antibody and other anti-heparanase antibodies
US7409963B2 (en) * 2004-11-05 2008-08-12 Go Papa, Lllp Corner molding and stop assembly for collapsible shelter
US8476070B2 (en) 2005-08-29 2013-07-02 Technion Research & Development Foundation Limited Media for culturing stem cells
DK3441459T3 (da) * 2006-08-02 2021-06-07 Technion Res & Dev Foundation Fremgangsmåder til ekspansion af embryonale stamceller i en suspensionskultur
JPWO2011125948A1 (ja) 2010-04-02 2013-07-11 独立行政法人理化学研究所 Ｅｓ細胞の製造方法
US10271876B2 (en) 2011-11-23 2019-04-30 Mezadata Medical Ip Holding Llc Method of in vitro fertilization with delay of embryo transfer and use of peripheral blood mononuclear cells
US10053485B2 (en) 2015-03-23 2018-08-21 Evestra, Inc. Cytotoxic agents that preferentially target leukemia inhibitory factor (LIF) for the treatment of malignancies and as new contraceptive agents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3643746A1 (de) * 1986-12-20 1988-06-30 Stohrer Doduco Gmbh & Co Tauchverfahren und vorrichtung zum elektrolytischen beschichten von platten, insbesondere von elektrischen leiterplatten
AU609128B2 (en) * 1987-04-02 1991-04-26 Amrad Operations Pty. Limited Leukaemia-inhibitory factor
WO1989007135A1 (en) * 1988-01-29 1989-08-10 Granada Genetics, Inc. Bovine embryo in vitro culture
EP0380646B1 (de) * 1988-08-04 1999-01-20 Amrad Corporation Limited (in vitro)-vermehrung von embryonalen stammzellen unter verwendung von leukämie-inhibitionsfaktor (lif)
CA2045126A1 (en) * 1989-01-10 1990-07-11 Nicholas M. Gough Leukaemia inhibitory factor from livestock species and use thereof to enhance implantation and development of embryonic cells
WO1992001040A1 (en) * 1990-07-09 1992-01-23 Amrad Corporation Limited Enhanced implantation, development and maintenance of embryos using leukaemia inhibitory factor

Also Published As

Publication number Publication date
JP2974760B2 (ja) 1999-11-10
NZ232072A (en) 1992-05-26
ATE142695T1 (de) 1996-09-15
EP0453453A1 (de) 1991-10-30
US5641676A (en) 1997-06-24
DE69028514T2 (de) 1997-02-20
EP0453453B1 (de) 1996-09-11
JPH04502554A (ja) 1992-05-14
US5418159A (en) 1995-05-23
CA2045126A1 (en) 1990-07-11
WO1990008188A1 (en) 1990-07-26
EP0453453A4 (en) 1992-10-14
US5962321A (en) 1999-10-05

Similar Documents

Publication Publication Date Title
DE69028514T2 (de) Leukämiehemmender faktor aus vieharten und seine verwendung zur verbesserung der implantation und der entwicklung von embryonalen zellen
Holtzer et al. The loss of phenotypic traits by differentiated cells in vitro, I. Dedifferentiation of cartilage cells
ATE12255T1 (de) Verfahren zur herstellung von selbstreproduzierenden pankreatischen inseln aehnlichen strukturen von saeugetieren.
DK720488D0 (da) Immunokompromitterede kimaerepattedyr og anvendelse heraf til fremstilling af celler og stoffer
DE69330945D1 (de) Tierzellenkultur
DE60017875D1 (de) Verwendung von collagenase in der zubereitung von neuralen stammzellkulturen
GB8413319D0 (en) Biological material
DE69231485D1 (de) Verwendung von porösem Calciumcarbonat als Trägermaterial für in vitro Zellkulturen.
Hashiba et al. Developmental changes in sclerotia of the rice sheath blight fungus
Rheinwald The role of terminal differentiation in the finite culture lifetime of the human epidermal keratinocyte
Lanotte et al. Collagen gels as a matrix for haemopoiesis
Fedoroff et al. Effect of horse serum on neural cell differentiation in tissue culture
DE69919531D1 (de) Aus normalem menschlichem hautgewebe immortalizierte zellinien
DE69230879D1 (de) Verwendung von Hepatocyten-Wachstumsfaktoren zur Herstellung eines Vermehrungssystems für Hematopoietische Stammzellen
Fischer et al. Improved conditions for murine epidermal cell culture
Arase et al. Culture of human outer root sheath cells from plucked hair follicles in serum-free conditions
Holeckova et al. Aging in cell and tissue culture
Maruyama Two types of spike generation of human Auerbach's plexus cells in culture
Groell et al. Stability of positional identity of axolotl blastema cells in vitro
Ellinger et al. Amphibian cell culture: established fibroblastic line from embryos of the discoglossid frog, Bombina orientalis
Kaneko et al. Mitosis in beating cardiac muscle cells from newt embryos in vitro
Fighetti et al. Possible involvement of nuclei in cadmium-induced modifications of cultured cells
ATE97958T1 (de) Zellenzuchtverfahren fuer die produktion von aktiviertem protein-c.
Pandharipande Two new continuously growing cell lines from Bombyx mori (Lepidoptera: Bombycidae)
Blüthmann et al. Enzyme activity profiles in mouse teratocarcinomas: a quantitative ultramicroscale analysis

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee